Titre

Estimated rates of treatment failure in first-line antiretroviral treatment in Kinshasa: Case of the ACS AMO-Congo

Type

Livre

Axe

Amélioration de l’accès aux soins et traitement,

Secteur

Santé,

Thématique

Soins et Traitement du VIH ,

Recherche

Science, Traitement et Soins cliniques,

Lieu

National,

Source

Chercheurs / Universités,

Auteur

KAMANGU NTAMBWE ERICK1*, KAWILA MAFANDA EUPHRASIE2, MUKUMBI HENRI2, MVUMBI LELO GEORGES1

Nombbre de page

Année d'édition

2012

Description

Introduction In 2009, 5.25 million people living with HIV (PLHIV) are under Highly Active AntiRetroviral Treatment (HAART) in low-and middle-income as reported in 2010 the World Health Organization (WHO)1. The goal of HAART is to slow the progression to AIDS by reducing viral load to undetectable value and restoring immunity to a CD4 count above 500 cells/mm3 for patients infected with HIV2. In the Democratic Republic of Congo (DRC), the first line of treatment for HIV adopted since 2008 for the PLHIV is a combination of single-dose Azydothimidine (AZT), Lamivudine (3TC) and Nevirapine (NVP...